Liana Apostolova, MD is the associate dean of Alzheimer's disease research at Indiana University School of Medicine. Dr. Apostolova and others presented results of the phase 3 clinical trial of Donanemab at the Alzheimer's Association International Conference. The study, also published recently in JAMA, showed Donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's disease. 

Apostolova is available for interviews about the trial results. .

MEDIA CONTACT
Register for reporter access to contact details
RELEVANT EXPERTS
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Alzheimer's and Dementia Clinical Trials Neuro Pharmaceuticals
KEYWORDS
Indiana University School of Medicine Indiana University IU Iu School Of Medicine Alzheimer's Disease Alzheimer's Disease
COMMENTS | COMMENTING POLICY